Online first
Letter to the Editor
Published online: 2024-09-27
Investigating biomarkers: a path to understanding long-COVID?
DOI: 10.5603/mrj.102231
Abstract
< p > < /p >
Keywords: long COVIDbiomarkersinflamationCOVID-19Biological Indicators
References
- Smykiewicz J, Wiacek M, Buczkowski J, et al. Markers of the outcome of COVID-19. Med Res J. 2024.
- Ranjbar M, Cusack RP, Whetstone CE, et al. Immune Response Dynamics and Biomarkers in COVID-19 Patients. Int J Mol Sci. 2024; 25(12).
- Ballering AV, van Zon SKR, Olde Hartman TC, et al. Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022; 400(10350): 452–461.
- Thaweethai T, Jolley SE, Karlson EW, et al. RECOVER Consortium. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023; 329(22): 1934–1946.
- Zanini G, Selleri V, Roncati L, et al. Vascular "Long COVID": A New Vessel Disease? Angiology. 2024; 75(1): 8–14.
- Cervia-Hasler C, Brüningk SC, Hoch T, et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024; 383(6680): eadg7942.